Matches in Wikidata for { <http://www.wikidata.org/entity/Q92393653> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q92393653 description "article scientifique publié en 2019" @default.
- Q92393653 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q92393653 description "scientific article published on 01 October 2019" @default.
- Q92393653 description "wetenschappelijk artikel" @default.
- Q92393653 description "наукова стаття, опублікована 1 жовтня 2019" @default.
- Q92393653 name "Phase I study on pegylated liposomal doxorubicin in combination with docetaxel for patients with platinum-resistant or partially platinum-sensitive epithelial ovarian cancer: The Kansai Clinical Oncology Group study" @default.
- Q92393653 name "Phase I study on pegylated liposomal doxorubicin in combination with docetaxel for patients with platinum-resistant or partially platinum-sensitive epithelial ovarian cancer: The Kansai Clinical Oncology Group study" @default.
- Q92393653 type Item @default.
- Q92393653 label "Phase I study on pegylated liposomal doxorubicin in combination with docetaxel for patients with platinum-resistant or partially platinum-sensitive epithelial ovarian cancer: The Kansai Clinical Oncology Group study" @default.
- Q92393653 label "Phase I study on pegylated liposomal doxorubicin in combination with docetaxel for patients with platinum-resistant or partially platinum-sensitive epithelial ovarian cancer: The Kansai Clinical Oncology Group study" @default.
- Q92393653 prefLabel "Phase I study on pegylated liposomal doxorubicin in combination with docetaxel for patients with platinum-resistant or partially platinum-sensitive epithelial ovarian cancer: The Kansai Clinical Oncology Group study" @default.
- Q92393653 prefLabel "Phase I study on pegylated liposomal doxorubicin in combination with docetaxel for patients with platinum-resistant or partially platinum-sensitive epithelial ovarian cancer: The Kansai Clinical Oncology Group study" @default.
- Q92393653 P1433 Q92393653-0E83672C-3AB3-46F7-9232-893A95BD3EE2 @default.
- Q92393653 P1476 Q92393653-40D185DF-4D21-4C53-A960-08B54C9BB077 @default.
- Q92393653 P2093 Q92393653-1CE88F8A-6C6F-45D1-92CD-64407A05F1DD @default.
- Q92393653 P2093 Q92393653-342207A3-44BE-4CD2-AB09-ED0349E933A5 @default.
- Q92393653 P2093 Q92393653-50B84532-929C-405E-A94C-090325246405 @default.
- Q92393653 P2093 Q92393653-9150A5BD-2FA4-43E8-AF43-8007586703FE @default.
- Q92393653 P2093 Q92393653-A0288A72-E3CD-47BD-980C-AC26013D78F2 @default.
- Q92393653 P2093 Q92393653-D660FD67-EC23-4A92-A8FF-EA4AFAB13F19 @default.
- Q92393653 P2093 Q92393653-FAF97CE2-4A56-4D86-99D3-37147A9815D0 @default.
- Q92393653 P304 Q92393653-8AEC7722-8171-496E-8BCD-CA4EDFD3F77D @default.
- Q92393653 P31 Q92393653-3102381C-C353-4CED-AD3D-3D45F5E11BD3 @default.
- Q92393653 P356 Q92393653-18D3387F-1A55-4C1B-BF9B-1949E438EBA9 @default.
- Q92393653 P433 Q92393653-EB4BEF24-2993-4A18-85C0-9DA95F0AB494 @default.
- Q92393653 P478 Q92393653-D5C4AEA2-5732-404E-ABC3-2607EEB594BA @default.
- Q92393653 P577 Q92393653-36E60038-A3AB-4153-9D51-5BC910BB3C19 @default.
- Q92393653 P698 Q92393653-7EEACE05-C737-4D03-B1C7-E89C170E67EB @default.
- Q92393653 P921 Q92393653-05EF3811-6289-495C-ADC7-898DA691DB4F @default.
- Q92393653 P921 Q92393653-1CC558DD-2BFC-4A1B-BF0D-8E89A3E5EEC8 @default.
- Q92393653 P921 Q92393653-65E751CD-7514-4F19-9D4F-13FBE4AAAC07 @default.
- Q92393653 P921 Q92393653-C717FA1E-519B-42A6-858C-FB228B6D62FE @default.
- Q92393653 P921 Q92393653-CFFEA832-C119-4593-8C85-4206BF0FC066 @default.
- Q92393653 P356 JCRT.JCRT_742_16 @default.
- Q92393653 P698 31898647 @default.
- Q92393653 P1433 Q400140 @default.
- Q92393653 P1476 "Phase I study on pegylated liposomal doxorubicin in combination with docetaxel for patients with platinum-resistant or partially platinum-sensitive epithelial ovarian cancer: The Kansai Clinical Oncology Group study" @default.
- Q92393653 P2093 "Atsushi Arakawa" @default.
- Q92393653 P2093 "Hiroshi Tsubamoto" @default.
- Q92393653 P2093 "Kensuke Hori" @default.
- Q92393653 P2093 "Kentaro Kuritani" @default.
- Q92393653 P2093 "Kimihiko Ito" @default.
- Q92393653 P2093 "Naoto Furukawa" @default.
- Q92393653 P2093 "Shiho Kuji" @default.
- Q92393653 P304 "1201-1206" @default.
- Q92393653 P31 Q13442814 @default.
- Q92393653 P356 "10.4103/JCRT.JCRT_742_16" @default.
- Q92393653 P433 "6" @default.
- Q92393653 P478 "15" @default.
- Q92393653 P577 "2019-10-01T00:00:00Z" @default.
- Q92393653 P698 "31898647" @default.
- Q92393653 P921 Q12322152 @default.
- Q92393653 P921 Q172341 @default.
- Q92393653 P921 Q18936 @default.
- Q92393653 P921 Q420436 @default.
- Q92393653 P921 Q880 @default.